4SC AG Company Description

4SC AG, a biopharmaceutical company, engages in developing small-molecule drugs that address cancer diseases with high unmet medical needs in Germany.

Its product Resminostat, an orally administered histone deacetylase inhibitor for the treatment of cutaneous T-cell lymphoma, which is in clinical development stage.

The company also out-licenses its products to pharma and biotech companies. The company was founded in 1997 and is headquartered in Planegg, Germany.

4SC AG

Country	Germany
Founded	1997
Industry	Biological Products, Except Diagnostic Substances
Employees	13
CEO	Jason Loveridge

Contact Details

Address: Fraunhoferstraße 22 Planegg, 82152 Germany
Phone	49 89 700 763 0
Website	4sc.com

Stock Details

Ticker Symbol	VSC
Exchange	Frankfurt Stock Exchange
Fiscal Year	January - December
Reporting Currency	EUR
SIC Code	2836

Key Executives

Name	Position
Jason Loveridge	Chief Executive Officer
Kathleen Masch-Wiest	Chief Operating Officer
Anna Niedl	Head of Investor Relations